A Randomized Phase III Trial of Postoperative Adjuvant Therapy with S-1 Alone versus S-1 plus PSK for Stage II/IIIA Gastric Cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)-Reference-Cited by-同舟云学术

A Randomized Phase III Trial of Postoperative Adjuvant Therapy with S-1 Alone versus S-1 plus PSK for Stage II/IIIA Gastric Cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC)

Published:2006-06-27 Issue:8 Volume:36 Page:519-522
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ueda Yuji,Fujimura Takashi,Kinami Shinichi,Hirono Yasuo,Yamaguchi Akio,Naitoh Hiroyuki,Tani Tohru,Kaji Masahide,Yamagishi Hisakazu,Miwa Koichi

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/36/8/519/5109830/hyl048.pdf

Reference11 articles.

1. Kinoshita T, Nakajima T, Ohashi Y. National Surgical Adjuvant Study Group for Gastric Cancer (N-SAS-GC). Adjuvant chemotherapy with uracil-tegafur (UFT) for serosa negative advanced gastric cancer: results of a randomized trial by national surgical adjuvant study of gastric cancer. Proc Am Soc Clin Oncol2005;23:313.

2. Shirasaka T, Shimamoto Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, et al. Development of a novel form of an oral fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulation. Anticancer Drugs1996;7:548–57.

3. Koizumi W, Kurihara M, Nakano S, Hasegawa K. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology2000;58:191–7.

4. Tsuburaya A, Sakamoto J, Morita S, Kodera Y, Kobayashi M, Miyashita Y, et al. A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the stomach cancer adjuvant multi-institutional trial group (samit) trial. Jpn J Clin Oncol2005;35:672–5.

5. Kato M, Hirose K, Hakozaki M, Ohno M, Saito Y, Izutani R, et al. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother1995;40:152–6.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Mechanisms of Polysaccharides against Gastric Cancer;Molecules;2022-09-08

2. Cutting-edge evidence of adjuvant treatments for gastric cancer;Expert Review of Gastroenterology & Hepatology;2018-10-10

3. Preclinical Antileukemia Activity of Tramesan: A Newly Identified Bioactive Fungal Metabolite;Oxidative Medicine and Cellular Longevity;2017

4. Coriolus versicolor mushroom polysaccharides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways;Molecular Immunology;2015-03

5. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway;Oncology Reports;2014-11-28